Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Biogen Idec
(NQ:
BIIB
)
190.16
+0.61 (+0.32%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Biogen Idec
< Previous
1
2
...
29
30
31
32
33
34
35
36
37
...
47
48
Next >
10 Biggest Price Target Changes For Friday
February 04, 2022
JP Morgan boosted the price target for Amazon.com, Inc. (NASDAQ: AMZN) from $4,350 to $4,500. Amazon shares jumped 11% to $3,081.07 in pre-market trading.
Via
Benzinga
Facebook FB plunges but Amazon AMZN surges: Earnings and Your Updated Price Levels
February 03, 2022
It seems like yesterday we were discussing the surge in Alphabet shares, and today we're focusing on big moves - currently in opposite directions - of Facebook and Amazon, all major market cap...
Via
Talk Markets
Biogen's Alzheimer's Drug Clocks Q4 Sales Of Just $1M, FY22 Earnings Guidance Below Consensus
February 03, 2022
Biogen Inc (NASDAQ: BIIB) posted Q4 sales of 2.73 billion, beating the consensus of $
Via
Benzinga
The Daily Biotech Pulse: Big Pharma Earnings Prove Lackluster, Mersana Inks $1B ADC R&D Deal, Syros Gets Orphan Drug Designation
February 03, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Recap: Biogen Q4 Earnings
February 03, 2022
Biogen (NASDAQ:BIIB) reported its Q4 earnings results on Thursday, February 3, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Earnings Scheduled For February 3, 2022
February 03, 2022
Companies Reporting Before The Bell • Tuesday Morning (NASDAQ:TUEM) is likely to report earnings for its second quarter.
Via
Benzinga
Biogen Snags $2.3 Billion In Samsung Biosimilars Deal; So, What's Next?
January 28, 2022
Analysts say the company could make an acquisition or another strategic move.
Via
Investor's Business Daily
Stocks That Hit 52-Week Lows On Thursday
February 03, 2022
On Thursday, 105 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week Lows And Highs: Meta Platforms (NASDAQ:FB) was the biggest company on...
Via
Benzinga
Biogen: Q4 Earnings Insights
February 03, 2022
Biogen (NASDAQ:BIIB) reported its Q4 earnings results on Thursday, February 3, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Biogen's Alzheimer's Struggles Continue; 'Minimal' Sales Expected This Year
February 03, 2022
Biogen's new Alzheimer's drug generated $1 million in fourth-quarter sales.
Via
Investor's Business Daily
Biogen Sells Biosimilar-Venture Stake To Samsung Biologics For $2.3B
January 28, 2022
Biogen Inc (NASDAQ: BIIB) is selling its stake in a pharmaceutical joint venture with the South Korean conglomerate Samsung for $2.3 billion.
Via
Benzinga
Earnings Preview For Biogen
February 02, 2022
Biogen (NASDAQ:BIIB) is set to give its latest quarterly earnings report on Thursday, 2022-02-03. Here's what investors need to know before the announcement. Analysts estimate that Biogen will likely...
Via
Benzinga
World Markets News for Tuesday
February 01, 2022
Exxon is splitting into 3 with its new restructuring move: upstream; chemicals; and low-carbon.
Via
Talk Markets
Biogen Exercises Option To Participate Developing Genentech's Bispecific Antibody, Mosunetuzumab
February 01, 2022
Biogen Inc (NASDAQ: BIIB) has
Via
Benzinga
The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News
January 31, 2022
The broader market weakness pervaded into the biotech sector in the week ending Jan. 28, sending stocks lower.
Via
Benzinga
AskSlim Market Week - Friday, Jan. 28
January 28, 2022
Technical and cycle analysis, and market commentary.
Via
Talk Markets
The Daily Biotech Pulse: Biogen Liquidates Out Of Biosimilar JV, Provention Bio Plots Diabetes Drug Resubmission, Merck Finds COVID Pill Effective Against Omicron
January 28, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
10 Biggest Price Target Changes For Monday
January 24, 2022
SVB Leerink cut Biogen Inc. (NASDAQ:BIIB) price ...
Via
Benzinga
14 Stocks in the Healthcare Sector
January 21, 2022
Here are 14 companies in the Healthcare Sector that have investment-grade credit ratings of BBB- or better, cash flow yield of 6% or better, future total return of at least 5%.
Via
Talk Markets
10 Biggest Price Target Changes For Tuesday
January 18, 2022
Keybanc raised J.B. Hunt Transport Services, Inc. (NASDAQ:
Via
Benzinga
Stock Market Rebound Fizzles Amid Hawkish Fed; Taiwan Semiconductor Breaks Out, JPMorgan Tumbles: Weekly Review
January 14, 2022
A rebound from Monday's lows faded, with the key indexes all down for the week.
Via
Investor's Business Daily
Two Curses Of The Current Year
January 13, 2022
The good news on inflation after this week's shocker is that December wholesale prices only rose 0.2%.
Via
Talk Markets
Denali Stock Tumbles; Why Biogen Isn't The Only Alzheimer's Play Under Pressure
January 13, 2022
Denali Therapeutics is under pressure after the FDA put its study on hold.
Via
Investor's Business Daily
3 Biotech Stocks to Buy That Are Under Severe Pressure
January 13, 2022
The biotech sector is prone to surprise headlines. But these biotech stocks to buy today have had fallen so much that they hit bottom.
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For January 13, 2022
January 13, 2022
Upgrades According to Morgan Stanley, the prior rating for SunPower Corp (NASDAQ:
Via
Benzinga
Why Jim Cramer Prefers This Mining Stock Over Vale
January 13, 2022
On CNBC’s "Mad Money Lightning Round," Jim Cramer said ChargePoint Holdings, Inc. (NYSE:
Via
Benzinga
10 Biggest Price Target Changes For Thursday
January 13, 2022
RBC Capital boosted KB Home (NYSE: KBH) price target from $46 to $55. KB Home shares rose 6.7% to $45.20 in pre-market trading. Cowen & Co. reduced the price target on...
Via
Benzinga
This Is What Whales Are Betting On Biogen
January 12, 2022
Someone with a lot of money to spend has taken a bearish stance on Biogen (NASDAQ:BIIB). And retail traders should know. We noticed this today when the big position showed up on...
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
January 12, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our...
Via
Benzinga
50 Biggest Movers From Yesterday
January 13, 2022
Gainers electroCore, Inc. (NASDAQ: ECOR) shares jumped 64% to settle at $0.88 on Wednesday after the company's gammaCore nVNS device received FDA Breakthrough Designation for...
Via
Benzinga
< Previous
1
2
...
29
30
31
32
33
34
35
36
37
...
47
48
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.